Prostate cancer AI diagnosis tool begins evaluation in Oxford
New artificial intelligence software that can help to spot prostate cancer is being trialled by researchers at Oxford University Hospitals (OUH) NHS Foundation Trust Researchers and clinicians in Oxford have begun an evaluation of artificial intelligence (AI) software that could help pathologists diagnose prostate cancer. Testing of the technology in a clinical setting, which is […]
Paige and Mindpeak Launch an Integrated Solution for Enhanced Cancer Diagnosis
NEW YORK–(BUSINESS WIRE)–Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications, today announced the availability of Mindpeak’s AI algorithms for IHC biomarker quantification in the Paige Platform. Mindpeak, a leader in image analysis AI software, brings state-of-the-art AI algorithms for analyzing IHC slides of lung and breast tissue into the Paige Platform. […]
Paige Named Award Recipient of the PathLAKE Plus AI Project under HealthTrust Europe’s National Tender for Artificial Intelligence Solutions
Paige has been awarded the opportunity to provide, if chosen, artificial intelligence applications to leading NHS Trust labs through PathLAKE Plus, a consortium dedicated to driving AI innovation in pathology for the UK. Through the digitization of five major NHS laboratories and the formation of a computational pathology hub, PathLAKE aims to ensure that the […]
The future is now: AI and more effective cancer screening
AI offers a host of benefits for cancer care, especially as the market develops and adoption increases. As the first and only company to receive FDA approval for an AI in pathology, Paige has been blazing the trail forward, and our Chief Medical Officer Dr. David Klimstra spoke with PharmaPhorum on how we envision AI […]
How digital biomarker assays can harness the power of deep learning from clinical trials to the clinic
“Just as much of medicine has begun to undergo a digital transformation in the past decade, so has pathology. Now, biomarkers, which are indications of particular features of cancer and are essential to diagnosis and treatment, are beginning their own digital revolution.” Dr. Joe Oakley, Medical Director of Biomarker Development at Paige, shared with Labiotech […]
Human Bytes partners with Paige to bring digital pathology and AI to Denmark and Sweden
Hellerup, Denmark January 19th 2023 Human Bytes are entering a strategic partnership with US-based Paige.AI, Inc. (“Paige”) to bring their leading end-to-end digital pathology solution and clinical AI applications to Denmark and Sweden. The field of pathology is facing a growing number of challenges with increased lab testing, a growing number of cancer cases, […]
Microsoft Is Aggressively Investing In Healthcare AI
Microsoft’s partnership with Paige is part of a larger trend the company has been following of investing heavily into AI, signaling their belief that AI technologies offer immense value across industries. In working together, Paige and Microsoft aim to help further the digitization of pathology and ensure that these tools are being used to get […]
Microsoft Strikes Partnership with Paige To Advance Cancer Diagnostics and Treatment
Paige has partnered with Microsoft to improve cancer diagnostics and patient care through the use of pathology AI. Through the partnership, Microsoft will make a strategic investment in Paige and Paige will adopt Microsoft Azure as their cloud provider for the Paige Platform. Paige CEO, Andy Moye, said of the partnership: “In Microsoft, we’ve really […]
Paige Collaborates with Microsoft to Transform Cancer Diagnosis and Treatment with the Use of Pathology AI
Companies to lead digital transformation of pathology and cancer diagnosis NEW YORK–(BUSINESS WIRE)–Paige announced a collaboration with Microsoft to apply the power of artificial intelligence (AI) to digital pathology images to develop and deliver a new generation of clinical applications and computational biomarkers to transform cancer diagnosis and patient care. Microsoft will also make a […]
IHC 0 HER2: Dr. Joe Oakley Speaks on Deep Learning-Based Assessment at SABCS 2022
Dr. Joe Oakley, Medical Director of Biomarker Development at Paige, sat down with OncologyTube to give an in-depth review our poster presented at SABCS 2022. The poster shares the findings of a study of our HER2Complete algorithm to determine if it can help pathologists uncover more details within the IHC 0 category of HER2 testing, […]
